cefepime + ceftriaxone
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Pneumonia
Conditions
Pneumonia
Trial Timeline
Mar 1, 2002 → Apr 1, 2006
NCT ID
NCT00358202About cefepime + ceftriaxone
cefepime + ceftriaxone is a approved stage product being developed by Elanco for Pneumonia. The current trial status is completed. This product is registered under clinical trial identifier NCT00358202. Target conditions include Pneumonia.
What happened to similar drugs?
4 of 20 similar drugs in Pneumonia were approved
Approved (4) Terminated (3) Active (14)
Hype Score Breakdown
Clinical
20
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00358202 | Approved | Completed |
Competing Products
20 competing products in Pneumonia